ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Rare Diseases : Delirium


Include trials that are no longer recruiting patients.

66 studies were found. Here are studies 1 to 50.
1.RecruitingMENDS Study
Condition: Delirium
2.RecruitingBiomarkers and Early Alzheimer's Disease
Condition: Alzheimer's Disease
3.RecruitingPredictors of Cognitive Decline in Normal Aging
Conditions: Alzheimer Disease; Dementia
4.RecruitingPET Changes in Alzheimer's Disease (AD)
Condition: Alzheimer Disease
5.RecruitingSGS742 in Patients with Mild to Moderate Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
6.RecruitingFish Oil and Alpha Lipoic Acid in Treating Alzheimer’s Disease
Conditions: Alzheimer's Disease; Oxidative Stress; Dementia; Hyperlipidemia; Inflammation
7.RecruitingThe Safety and Efficacy of Neramexane in Patients with Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
8.RecruitingRisk Evaluation and Education for Alzheimer’s Disease (REVEAL) II
Condition: Alzheimer Disease
9.RecruitingTreatment Study of Frontotemporal Dementia
Condition: Frontotemporal Lobar Degeneration
10.RecruitingEvaluation of Alzhemed™ in Patients with Mild to Moderate Alzheimer’s Disease
Condition: Alzheimer Disease
11.RecruitingEffect of Lithium and Divalproex in Alzheimer's Disease
Condition: Alzheimer Disease
12.RecruitingCERE-110 in Subjects with Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
13.RecruitingA Randomized Study to Evaluate FK962 in Subjects with Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
14.RecruitingDepression in Alzheimer's Disease (DIADS-2)
Conditions: Alzheimer's Disease; Depression
15.RecruitingHuperzine A in Alzheimer's Disease
Condition: Alzheimer Disease
16.RecruitingEffects of ONO-2506PO in Patients with Alzheimer's Disease
Condition: Alzheimer's Disease
17.RecruitingSafety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer’s Disease
Condition: Alzheimer's Disease
18.RecruitingMontessori-Based Activities for Elderly Persons with Dementia
Condition: Dementia
19.RecruitingDirect Current Brain Polarization in Frontotemporal Dementia
Condition: Pick Disease of the Brain
20.RecruitingAntigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study
Condition: Alzheimer Disease
21.RecruitingTreating Behavioral Disturbances in Individuals with Dementia
Conditions: Dementia; Alzheimer Disease
22.RecruitingValproate in Dementia (VALID)
Condition: Alzheimer Disease
23.RecruitingAlzheimer's Disease: Therapeutic Potential of Estrogen
Condition: Alzheimer Disease
24.RecruitingCognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
Condition: Alzheimer Disease
25.RecruitingHigh Intensity Light Therapy in Alzheimer's Disease
Conditions: Alzheimer's Disease; Dementia
26.RecruitingDelaying Alzheimer Disease Symptoms with Anti-Inflammatory Drugs
Conditions: Alzheimer Disease; Dementia
27.RecruitingAlzheimer's Disease Genetics Study
Conditions: Alzheimer Disease; Late Onset Alzheimer Disease
28.RecruitingTherapy for Reading Problems in Adults After Brain Injury
Conditions: Dyslexia, Acquired; Brain Injuries; Cerebrovascular Accident
29.RecruitingBathing persons with Alzheimer's disease aT Home (The BATH Study)
Condition: Alzheimer Disease
30.RecruitingAlzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II
Condition: Alzheimer Disease
31.RecruitingSafety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying)
Conditions: Amyotrophic Lateral Sclerosis; Multiple Sclerosis; Alzheimer's Disease; Stroke; Traumatic Brain Injury
32.RecruitingVitamin E in Aging Persons With Down Syndrome
Conditions: Down Syndrome; Alzheimer Disease
33.RecruitingReducing Depression in Caregivers to People with Dementia
Conditions: Dementia; Depression
34.RecruitingVITAL - VITamins to slow ALzheimer's disease (Homocysteine Study)
Condition: Alzheimer's Disease
35.RecruitingNS 2330 in Patients with Mild to Moderate Dementia of the Alzheimer’s Type
Condition: Alzheimer Disease
36.RecruitingCholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study
Condition: Alzheimer Disease
37.RecruitingTherapy for Depressed Elders with Thought Problems
Conditions: Depression; Cognition Disorders
38.RecruitingEfficacy and Safety of LY451395 in Patients with Probable Alzheimer's Disease
Condition: Alzheimer's Disease
39.RecruitingPhytoestrogens and Memory Decline in Menopause
Conditions: Memory Loss; Postmenopausal Period
40.RecruitingThe Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated with Alzheimer's Disease
Condition: Alzheimer Disease
41.RecruitingTreatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
Conditions: Dementia; Parkinson Disease
42.RecruitingMohawk Culture, Behavior, Toxicant Exposure and Health
Conditions: Thyroid Diseases; Cognition Disorders
43.RecruitingHuman Epilepsy Genetics--Neuronal Migration Disorders Study
Conditions: Epilepsy; Seizures; Cognition Disorders; Neuronal Migration Disorders
44.RecruitingPrevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
Condition: Alzheimer Disease
45.RecruitingPrevention of cognitive decline in Alzheimer's disease by ingested interferon alpha
Conditions: Memory Disorders; Alzheimer's Disease
46.RecruitingEvaluation of Age- and Alzheimer's Disease-Related Memory Disorder
Conditions: Alzheimer Disease; Dementia; Memory Disorder; Healthy
47.RecruitingA Study of Decreased Mental Function Associated with HIV
Conditions: Cognitive Disorders; HIV Infections
48.RecruitingGene-Environment Interactions in Alzheimer's Disease
Condition: Alzheimer's Disease
49.RecruitingInsulin, Neurogenetics and Memory in Alzheimer's Disease
Condition: Alzheimer Disease
50.RecruitingAlzheimer's Disease and Aging: Therapeutic potential of estrogen
Condition: Alzheimer's Disease

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act